Go to the list of all blogs
published in Blogs
Jul 16, 2026
ProShares VIX Short-Term Futures ETF (VIXY): Tactical Hedging in a Low-Volatility Market with -8% Monthly and -29% Quarterly Declines

ProShares VIX Short-Term Futures ETF (VIXY): Tactical Hedging in a Low-Volatility Market with -8% Monthly and -29% Quarterly Declines

Key Takeaways

  • VIXY tracks the S&P 500 VIX Short-Term Futures Index, providing exposure to front-month and next-month VIX futures contracts rather than the spot VIX itself.
  • The ETF holds approximately five assets, primarily Cboe VIX futures contracts alongside cash equivalents and Treasury bills, and carries an expense ratio of 0.85%.
  • VIXY has declined roughly 8% over the past 30 days and approximately 29% over the trailing quarter, reflecting a sustained compression in implied equity market volatility.
  • The current low-VIX environment coexists with unusually elevated single-stock dispersion, creating a complex backdrop where index-level calm masks significant rotation beneath the surface.
  • Structural headwinds from contango — where longer-dated VIX futures trade above near-term contracts — continue to erode returns for long-term holders, reinforcing VIXY's role as a tactical rather than buy-and-hold instrument.
  • The trajectory of Federal Reserve policy under new Chair Kevin Warsh, geopolitical developments, and the AI-driven earnings cycle represent the most significant volatility catalysts for the remainder of 2026.

A Closer Look at the ProShares VIX Short-Term Futures ETF (VIXY)

The ProShares VIX Short-Term Futures ETF seeks investment results, before fees and expenses, that match the performance of the S&P 500 VIX Short-Term Futures Index. Launched in January 2011 by ProShare Capital Management LLC, the fund is structured as a passively managed commodity pool that gains exposure to equity market volatility through publicly traded VIX futures markets. It does not invest directly in equities.

VIXY's portfolio is concentrated, typically holding four to five assets. The largest positions consist of front-month and second-month Cboe VIX futures contracts, which are continuously rolled to maintain average one-month maturity exposure. Cash management is handled through an affiliated money market ETF — the ProShares Genius Money Market ETF (IQMM) — along with U.S. Treasury bills. As of mid-2026, the fund's assets under management (AUM) stood at approximately $200 million to $230 million, with an expense ratio of 0.85%.

A defining structural feature of VIXY is its vulnerability to contango, the condition in which longer-dated futures contracts trade at a premium to near-term contracts. During calm market periods, the fund repeatedly sells cheaper expiring contracts and buys more expensive deferred contracts, creating a persistent performance drag. This dynamic makes VIXY most suitable as a short-term hedging tool rather than a long-term portfolio allocation.

Industry and Thematic Landscape

The volatility exchange-traded product landscape has been shaped in 2026 by a pronounced divergence between the CBOE Volatility Index (VIX), which has remained in a relatively subdued range between roughly 15 and 22, and single-stock volatility measures that have reached multi-decade extremes. The S&P 500 dispersion index has surged near 50, while the VIX has hovered around 16, a gap that Bank of America has described as historically unprecedented and reminiscent of patterns seen before the 2000 dot-com peak.

Several macro forces have driven this dynamic. The U.S.-Iran ceasefire agreement in late spring sharply reduced geopolitical risk premiums, sending crude oil prices down more than 20% and removing a key source of market anxiety. Meanwhile, the artificial intelligence investment cycle has created enormous dispersion within equity markets: semiconductor stocks have soared while mega-cap hyperscalers have faced profit-taking, generating churn beneath a placid index-level surface. The S&P 500 posted a roughly 17% gain in the second quarter of 2026, yet June alone saw a notable rotation out of technology and communication services into industrials, healthcare, and financials.

Monetary policy has added another layer of complexity. Federal Reserve Chair Kevin Warsh struck a more hawkish tone at his first policy meeting, removing forward guidance and leaving the door open to additional rate hikes. The yield curve has flattened, with short-term rates rising while long-term yields declined, reflecting a market that is repricing the path of monetary policy against a backdrop of still-elevated inflation.

Performance and Positioning Snapshot

VIXY has experienced a meaningful decline over recent months, losing approximately 8% in the trailing 30-day period and roughly 29% over the trailing quarter. The ETF moved from the $28 range in mid-April to the low-$20 range by mid-July, with the descent largely tracking the steady compression in the spot VIX from elevated levels earlier in the year.

The primary driver of this decline has been the broad easing of macro-level volatility. The VIX itself fell from levels above 30 during the peak of U.S.-Iran tensions in March to the mid-teens by July, as ceasefire negotiations progressed, oil prices normalized, and equity markets staged a powerful rebound. Additionally, the persistent contango structure in VIX futures has compounded the downward pressure. During the second quarter, front-month VIX futures commanded a premium over spot VIX, and second-month futures traded at an even wider premium, meaning VIXY's daily contract rolls consistently occurred at a cost.

The performance pattern also reflects how VIXY responds to the type of volatility the market is experiencing. The current environment features high single-stock dispersion concentrated in technology and semiconductor names, which affects equity-specific volatility measures far more than the broad S&P 500 implied volatility that VIX futures track. As a result, even as individual stocks have experienced dramatic swings — memory chip makers entering bear-market territory while software names rallied — the index-level VIX has remained contained, offering limited support to VIXY.

AI Screener

In a market environment defined by rapid sector rotation and stark divergence between index-level calm and single-stock turbulence, identifying actionable trade ideas requires tools that can process vast amounts of data efficiently. Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that enables investors to scan thousands of securities using technical indicators, fundamental metrics, volatility measures, AI-generated signals, price patterns, and customizable industry filters. The platform helps users surface trending securities, breakout candidates, and tactical opportunities that manual screening might overlook. For investors seeking to navigate today's fragmented market landscape with greater precision, the AI Screener offers a data-driven starting point.

2026 Outlook and Key Factors to Monitor

Several structural factors are likely to influence VIXY and the broader volatility complex through the remainder of 2026. Federal Reserve policy under Chair Warsh remains the most significant macro variable. If inflation proves stickier than anticipated — partly due to AI-driven memory chip demand fueling price increases in technology hardware — the Fed may maintain a restrictive stance longer than markets currently price, potentially reigniting volatility across equities and fixed income simultaneously.

The midterm election cycle introduces another layer of uncertainty. Historically, equity volatility tends to rise in the months leading into November midterm elections as policy uncertainty increases. Combined with ongoing questions about AI infrastructure spending — which has surpassed $700 billion — and whether hyperscaler capital expenditures will generate adequate returns, the potential for a reassessment of technology sector valuations could drive the VIX higher from current compressed levels.

Geopolitical risk, while diminished, has not disappeared. The U.S.-Iran ceasefire includes a 60-day negotiation window, and periodic flare-ups in the Strait of Hormuz region could quickly reprice energy markets and equity volatility. Additionally, the record gap between the VIX and single-stock dispersion measures represents a structural tension that may resolve through either a rise in index-level volatility or a decline in single-stock turbulence — either path carries implications for VIXY positioning.

For VIXY specifically, the contango regime remains the dominant structural consideration. Even if the VIX rises moderately, the fund's returns may be muted if the futures curve remains steeply upward-sloping. Investors evaluating VIXY should monitor the shape of the VIX futures term structure, Fed communications, earnings season surprises, and geopolitical headlines as the most direct inputs into near-term volatility expectations.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: VIXY

Momentum Indicator for VIXY turns negative, indicating new downward trend

VIXY saw its Momentum Indicator move below the 0 level on July 31, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned negative. In of the 82 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for VIXY turned negative on August 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIXY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VIXY broke above its upper Bollinger Band on July 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for VIXY entered a downward trend on July 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for VIXY's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VIXY advanced for three days, in of 194 cases, the price rose further within the following month. The odds of a continued upward trend are .

Industry description

The investment seeks investment results, before fees and expenses, that over time, match the performance of the S&P 500 VIX Short-Term Futures Index for a single day. The index seeks to offer exposure to market volatility through publicly traded futures markets and is designed to measure the implied volatility of the S&P 500 over 30 days in the future.
View a ticker or compare two or three
VIXY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Details
Category
Trading--Miscellaneous
Address
ProShares Trust II7501 WISCONSIN AVEBethesda
Phone
240-497-6400
Web
www.proshares.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.